MedPath

clinical evaluation of siddha drug kukkilathi chooranam in excessive white discharge(leucorrhoea)patients of age group 18 to 60

Phase 2
Not yet recruiting
Conditions
Candidiasis of vulva and vagina,
Registration Number
CTRI/2019/08/020842
Lead Sponsor
Government siddha medical college
Brief Summary

This is a non randomized open clinical trial to evaluate the safety and efficacy of siddha trial drug kukkilathi chooranam in vulvo vaginal candidiasis patients of age between 18 to 60.clinical trial will be conducted  after completion of preclinical trial study.All the collected data will be documented.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
20
Inclusion Criteria

patients with the symptoms of whitish (curdy like) discharge vulvovaginal itching erosions inflammation surface is covered by whitish coat known case of DM positive candida albicans.

Exclusion Criteria

Known case of sexually transmitted disease (Gonorrhea,Syphilis,HIV) Known case of Nonspecific leucorrhea (Douches,Pessaries,tampons,trauma,drugs,chemicals) Pregnancy and lactation Known case of malignancy in uterus and ovary Vulvovagainosis caused by other organism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
outcome is assessed by wet mount examination and clinical prognosisAfter 48 days
Secondary Outcome Measures
NameTimeMethod
outcome is assessed by comparing the safety parameters before and after treatment48 days

Trial Locations

Locations (1)

Arignar Anna Government Hospital for Indian Medicine and homoeopathy

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Government Hospital for Indian Medicine and homoeopathy
🇮🇳Chennai, TAMIL NADU, India
Dr S Bharathi
Principal investigator
9486147810
sbharathi004@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.